Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Window of Health : Jurnal Kesehatan Jurnal Farmagazine
Dian Ratih L
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Chemistry Health Professions Immunology & microbiology Medicine & Pharmacology Nursing Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Analisis Efektivitas-Biaya Tindakan Kolesistektomi Metodelaparoskopidan Kolesistektomi Terbuka Pada Rs Swasta Tipe B Di Jakarta Pusat Tahun 2013 -2017 Diana Hayati; Ahmad Fuad Afdhal; Dian Ratih L
Jurnal Farmagazine Vol 5, No 3 (2018): Jurnal Farmagazine
Publisher : STF Muhammadiyah Tangerang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47653/farm.v5i3.109

Abstract

Kolelitiasis adalah penyakit yang dapat ditemukan di dalam kandung empedu atau di dalam ductus koledokus atau pada kedua-duanya. Dalam pelayanan kesehatan , tidak hanya outcome klinisyang diutamakan tetapi juga faktor pembiayaan. Untuk menentukan biaya yang efektif dan efisien diperlukan analisis farmakoekonomi. Salah satu tindakan yang memerlukan analisis efektifitas biaya adalah kolesistektomi yaitu tindakan pengangkatan batu empedu. Tujuan dari penelitian ini adalah untuk membandingkan efektif-biaya kolesistektomi metode laparoskopi dengan kolesistektomi terbuka (open surgery). Penelitian ini merupakan studi potong lintang, retrospektif dengan menggunakan data rekam medis penderita kolelithiasis di RS Swasta Kelas B di Daerah Jakarta Pusat tahun 2013-2017. Jumlah sampel 72 pasien yang terdiri dari 36 sampel kolesistektomi laparoskopi, dan 36 sampel kolesistektomi terbuka. Analisa farmakoekonomi belum pernah dilakukan di RS Swasta kelas B di daerah Jakarta Pusat. Parameter yang digunakan dalam penelitian ini adalah biaya pengobatan langsung yang meliputi biaya total, biaya pemeriksaan, biaya ruang perawatan, obat-obatan, dan alat kesehatan, sedangkan indikator efektivitasnya menggunakan lama hari rawat inap. Hasil menunjukkan bahwa rata-rata biaya langsung kolesistektomi laparoskopi dibanding metode terbuka lebih besar. Rasio efektifitas biaya kolesistektomi laparoskopi perharilebih besar dibanding metode terbuka.Perhitungan rasio efektivitas biaya tambahan (ICER) menunjukkan bahwa kolesistektomi laparoskopi memiliki biaya lebih rendah dibandingkan dengan kolesistektomi terbuka. Dapat disimpulkan bahwa kolesistektomi laparoskopi lebih efektif-biaya daripada kolesistektomi terbuka. Kata Kunci: Kolesistektomi, Kolesistektomi Laparoskopi, Kolesistektomi Terbuka, Cost Effective Ratio
Survival Analysis and Risk Factors for COVID-19 Patients at Koja Hospital Kemal Pradana Putra; Dian Ratih L; Hesty Utami R; Rita Novariani; Natasja R Kandou
Window of Health : Jurnal Kesehatan Vol 7 No 2 (April 2024)
Publisher : Fakultas Kesehatan Masyarakat Universitas Muslim Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33096/woh.vi.773

Abstract

The COVID-19 pandemic impacts global health, and no specific drug has proven effective in curing SARS-CoV-2 infection. This study aimed to analyze the survival characteristics of COVID-19 patients in Koja Hospital. This research method is analytically observational with a cross-sectional design. The study population was 1080, and the research sample was 284 patients. The sampling used a purposive sampling method with a retrospective approach from the medical records of confirmed COVID-19 inpatients from May to October 2020. The analysis uses SPSS software version 26. Categorical variables were analyzed using the chi-square test or Fisher’s exact test. Kaplan Meier, Log Rank, and Cox Regression were used for the probability of survival analysis and mortality risk ratio in COVID-19 patients. The case fatality rate (CFR) of 284 COVID-19 patients was 20.4%. The mean age of the patients was 49 years (IQR 37–57). The most common comorbidity was hypertension, 34%. The average probability of survival of COVID-19 patients was above 60%. In addition to gender, predictors including age, comorbidities, type of intensive care, and use of antivirals had significant differences and affected the chances of survival of COVID-19 patients. Patients given oseltamivir monotherapy had the highest survival rate of about 80% after undergoing treatment for about 38 days (p equal 0.000). The mortality risk ratio of COVID-19 patients with comorbid diabetes mellitus was 8.7 times higher than that of those without comorbidities (95% CI 1,02–75.82, p less than 0.048). Patients with intensive care had an 11.43 times increased mortality risk ratio compared to usual care (95% CI 6,34–20,62, p less than 0.000). The conclusion of this study is intensive care and a history of diabetes mellitus are associated with the risk of death. There needs to be an increase in COVID-19 control measures, especially in populations prone to comorbid diabetes with severe and critical degrees.
Co-Authors Ahmad Fuad Afdhal Hayati, Diana Hesty Utami R Kemal Pradana Putra Natasja R Kandou Rita Novariani